Salt/Cocrystal of Anti-Fibrinolytic Hemostatic Drug Tranexamic acid: Structural, DFT, and Stability Study of Salt/Cocrystal with GRAS Molecules

Tranexamic acid (TXA) is an important and essential medicine needed in a health system and is approved by the US FDA for the treatment of excessive blood loss from trauma, postpartum bleeding, surgery, tooth removal, nosebleeds, and heavy menstruation. One of the notable disadvantages of the TXA drug is that has low absorption (∼35–40%) in the gastrointestinal tract, possibly due to its amphoteric nature. In the present work, nine molecular salts and two cocrystals of the TXA molecule have been synthesized by a simple water-mediated solvent evaporation method. The coformers/counterions used were salicylic acid (SAL), 3-hydroxybenzoic acid (3HBA), 2,4-dihydroxybenzoic acid (2,4HBA), 2,5-dihydroxybenzoic acid (2,5HBA), 2,6-dihydroxybenzoic acid (2,6HBA), gallic acid (GAA), oxalic acid (TXA), tartaric acid (TTA), fumaric acid (FUM), succinic acid (SUA), and crotonic acid (CRA). The synthesized salts/cocrystals were characterized by various spectroscopic, thermal, and XRD techniques. The crystal structures of...